Chemotherapy for spinal cord astrocytoma

Area of Science:

• Neuro-oncology
• Spinal Cord Neoplasms
• Chemotherapy

Background:

• Optimal management of spinal cord astrocytomas is undefined.
• Aggressive surgery and radiotherapy carry high morbidity risks.
• The role of chemotherapy is largely unassessed.

Observation:

• A patient presented with paraplegia due to an infiltrating spinal cord tumor.
• Biopsy confirmed a grade II astrocytoma.
• The patient received sequential chemotherapy with vincristine and carboplatin.

Findings:

• Complete radiological remission and full neurological recovery were achieved after eight months of chemotherapy.
• Treatment was discontinued at eleven months due to hypersensitivity.
• The patient remained in complete remission fourteen months post-treatment without radiotherapy.

Implications:

• Chemotherapy shows significant potential for spinal cord astrocytoma treatment.
• This approach could alter standard care if validated in larger studies.
• Chemotherapy may be a viable option alone or combined with radiotherapy.